Evidence map›Paper›PMID 33137919›Full record

ArticleJournal of clinical medicine2020

Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19.

Manuel Rubio-Rivas, Xavier Corbella, José María Mora-Luján, Jose Loureiro-Amigo, Almudena López Sampalo, Carmen Yera Bergua, Pedro Jesús Esteve Atiénzar, Luis Felipe Díez García, Ruth Gonzalez Ferrer, Susana Plaza Canteli and 15 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 4 pooled it
1.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 4 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Obesity as an independent risk factor for COVID-19 severity and mortality.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Genetic Screening forFrontiers in immunology · 2021
    Trial
  6. Article
  7. Article
  8. Article
  9. Post-COVID Patients With New-Onset Chronic Pain 2 Years After Infection: Cross-Sectional Study.Pain management nursing : official journal of the American Society of Pain Management Nurses · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Clinical-epidemiologic variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  14. Article
  15. Hyperlipidemia, COVID-19 and acute pancreatitis: A tale of three entities.The American journal of the medical sciences · 2022
    Review
  16. Article
  17. Article
  18. Observational
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 20 institutions in 1 country.

Manuel Rubio-RivasDepartment of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, 08907 Barcelona, Spain.
Xavier CorbellaDepartment of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, 08907 Barcelona, Spain.ORCID 0000-0001-9889-0272
José María Mora-LujánDepartment of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, 08907 Barcelona, Spain.
Jose Loureiro-AmigoInternal Medicine Department, Moisès Broggi Hospital, Sant Joan Despí, 08970 Barcelona, Spain.ORCID 0000-0002-6451-8971
Almudena López SampaloInternal Medicine Department, Regional University Hospital of Málaga, 29010 Málaga, Spain.
Carmen Yera BerguaInternal Medicine Department, Virgen de la Salud Hospital, 45071 Toledo, Spain.
Pedro Jesús Esteve AtiénzarInternal Medicine Department, San Juan de Alicante University Hospital, San Juan de Alicante, 03550 Alicante, Spain.
Luis Felipe Díez GarcíaInternal Medicine Department, Torrecárdenas Hospital, 04009 Almería, Spain.
Ruth Gonzalez FerrerInternal Medicine Department, Tajo Hospital, Aranjuez, 28300 Madrid, Spain.
Susana Plaza CanteliInternal Medicine Department, Severo Ochoa University Hospital, Leganés, 28914 Madrid, Spain.
Antía Pérez PiñeiroInternal Medicine Department, Valle del Nalón Hospital, Riaño, Langreo, 33920 Asturias, Spain.
Begoña Cortés RodríguezInternal Medicine Department, Alto Guadalquivir Hospital, Andújar, 23740 Jaén, Spain.
Leyre Jorquer VidalInternal Medicine Department, Francesc de Borja Hospital, Gandia, 46702 Valencia, Spain.
Ignacio Pérez CatalánInternal Medicine Department, Castellón General University Hospital, 12004 Castellón de la Plana, Spain.ORCID 0000-0002-2146-378X
Marta León TéllezInternal Medicine Department, Santa Bárbara Hospital, 42005 Soria, Spain.
José Ángel Martín OterinoInternal Medicine Department, Salamanca University Hospital Complex, 37007 Salamanca, Spain.ORCID 0000-0002-5598-5180
María Candelaria Martín GonzálezInternal Medicine Department, Canarias University Hospital, 38320 Santa Cruz de Tenerife, Spain.
José Luis Serrano Carrillo de AlbornozInternal Medicine Department, Poniente Hospital, 04700 Almería, Spain.
Eva García SardonInternal Medicine Department, San Pedro de Alcántara Hospital, 10003 Cáceres, Spain.
José Nicolás Alcalá PedrajasInternal Medicine Department, Pozoblanco Hospital, Pozoblanco, 14400 Córdoba, Spain.
Anabel Martin-Urda Diez-CansecoInternal Medicine Department, Palamós Hospital, Palamós, 17230 Girona, Spain.
María José Esteban GinerInternal Medicine Department, Virgen de los Lirios Hospital, Alcoy, 03804 Alicante, Spain.
Pablo Tellería GómezInternal Medicine Department, Valladolid Clinical University Hospital, 47003 Valladolid, Spain.
José Manuel Ramos-RincónDepartment of Clinical Medicine, Miguel Hernandez University of Elche, 03203 Alicante, Spain.ORCID 0000-0002-6501-9867
Ricardo Gómez-HuelgasInternal Medicine Department, Regional University Hospital of Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Malaga, Spain.ORCID 0000-0002-9909-3555
Bellvitge University Hospital · ESComplejo Hospitalario Torrecárdenas · ESHospital Alto Guadalquivir · ESHospital de Palamós · ESHospital de Poniente · ESHospital de Sant Joan Despí Moisès Broggi · ESHospital General Universitari de Castelló · ESHospital Monte Naranco · ESHospital Regional Universitario de Málaga · ESHospital San Pedro de Alcántara · ESHospital Universitario de Canarias · ESHospital Universitario del Tajo · ESHospital Universitario Severo Ochoa · ESHospital Universitari Sant Joan D'Alacant · ESHospital Valle del Nalón · ESHospital Virgen de la Salud · ESHospital Virgen de los Lirios · ESInstituto de Investigación Biomédica de Málaga · ESUniversidad de Salamanca · ESUniversidad de Valladolid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Different clinical presentations in COVID-19 are described to date, from mild to severe cases. This study aims to identify different clinical phenotypes in COVID-19 pneumonia using cluster analysis and to assess the prognostic impact among identified clusters in such patients. (2) Methods: Cluster analysis including 11 phenotypic variables was performed in a large cohort of 12,066 COVID-19 patients, collected and followed-up from 1 March to 31 July 2020, from the nationwide Spanish Society of Internal Medicine (SEMI)-COVID-19 Registry. (3) Results: Of the total of 12,066 patients included in the study, most were males (7052, 58.5%) and Caucasian (10,635, 89.5%), with a mean age at diagnosis of 67 years (standard deviation (SD) 16). The main pre-admission comorbidities were arterial hypertension (6030, 50%), hyperlipidemia (4741, 39.4%) and diabetes mellitus (2309, 19.2%). The average number of days from COVID-19 symptom onset to hospital admission was 6.7 (SD 7). The triad of fever, cough, and dyspnea was present almost uniformly in all 4 clinical phenotypes identified by clustering. Cluster C1 (8737 patients, 72.4%) was the largest, and comprised patients with the triad alone. Cluster C2 (1196 patients, 9.9%) also presented with ageusia and anosmia; cluster C3 (880 patients, 7.3%) also had arthromyalgia, headache, and sore throat; and cluster C4 (1253 patients, 10.4%) also manifested with diarrhea, vomiting, and abdominal pain. Compared to each other, cluster C1 presented the highest in-hospital mortality (24.1% vs. 4.3% vs. 14.7% vs. 18.6%;

Indexed as

cluster analysisCOVID-19phenotypeprognosis

Identifiers

PMID33137919
PMCPMC7693215
OpenAlexW3094792109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.